Search

everythinglearnresearchcommunity

for

Search:↓

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Metformin is less effective in men with early-onset hair loss.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Heavy metals might contribute to hair loss in Telogen Effluvium.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

Metabolites and diet affect hair growth cycles in cashmere goats.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.